Biomaterials Engineering and Testing core (BET)

Information

  • Research Project
  • 10233955
  • ApplicationId
    10233955
  • Core Project Number
    P30GM131959
  • Full Project Number
    5P30GM131959-03
  • Serial Number
    131959
  • FOA Number
    PAR-18-263
  • Sub Project Id
    8612
  • Project Start Date
    7/1/2019 - 5 years ago
  • Project End Date
    6/30/2024 - 10 months ago
  • Program Officer Name
  • Budget Start Date
    7/1/2021 - 3 years ago
  • Budget End Date
    6/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    03
  • Suffix
  • Award Notice Date
    7/28/2021 - 3 years ago
Organizations

Biomaterials Engineering and Testing core (BET)

The Phase III Biomaterials Engineering and Testing (BET) Core will support the synthesis and characterization of biomaterials and the design of biomaterial systems for research projects focused on the development of translational regenerative medicine applications for the treatment of human disease. The BET Core will provide both the facilities and staff necessary to provide this research support as well as training and mentoring for facilities users. The BET Core will build upon its track record of providing this type of support over the past 9 years under the Phase I & II COBRE grants and will substantial enhance its facilities for bioreactor system design, development, and biofabrication in order to support the extended in vivo research services to be offered by the Translational Research Imaging (TRI) Core. Over the past Phase I and II COBRE programs, the BET core has provided the facilities and support contributing to the publication of over 300 referred journal publications as well as the success of several of our junior investigators for attaining their own independent NIH R01 funding. Under the Phase III program, it is our objective to develop the BET Core into a sustainable resource to provide facilities for the continued support of translational regenerative medicine research well beyond the Phase III grant period.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    P30
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    227955
  • Indirect Cost Amount
    119676
  • Total Cost
  • Sub Project Total Cost
    347631
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIGMS:347631\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZGM1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CLEMSON UNIVERSITY
  • Organization Department
  • Organization DUNS
    042629816
  • Organization City
    CLEMSON
  • Organization State
    SC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    296340001
  • Organization District
    UNITED STATES